Clemex Discloses First Quarter Results
September 10 2012 - 11:23AM
PR Newswire (Canada)
5% increase in sales Symbol: CXG.A-CDNX www.clemex.com Shares
Outstanding: 30,999,810 MONTREAL, Sept. 11, 2012 /CNW Telbec/
- Clemex Technologies Inc. , designer and manufacturer of Image
Analysis systems and software for microscopy applications,
announces its financial results for the first Quarter of FY2013
ending July 31, 2012. For this first Quarter, sales reached
$1,305,152 an increase of $64,322 or 5% compared to the same period
last year. The Corporation ends this quarter with a Net Loss of
$44,265 compared to a Net Loss of $46,247 posted last year. During
this past Quarter, the Corporation made several sales to clients in
the manufacturing sector in North America: NUCOR Steel Mills,
Blytheville Arkansas, NSL Central Testing, Cleveland Ohio,
University of Toronto, Toronto Ontario and McMaster University,
Hamilton Ontario. On the International side, substantial
sales were made to Tenaris Silcotub in Romania, Renk Zanini, Brazil
and Nano S-Tech in South Korea. FINANCIAL HIGHLIGHTS First Quarter
July 31 Fiscal Year 2012 2011 $ $ Sales 1,305,152 1,240,830 Gross
Margin 664,866 668,172 Gross Margin % 50.9% 53.8% Total Operating
Expenses 681 131 686 419 Income Taxes 28,000 28,000 Net Loss
(44,265) (46,247) Net Loss per share (0.001) (0.002) Clement
Forget, President and CEO of Clemex Technologies Inc. declared:
"Given the circumstances of the market, we are satisfied with our
results for this First Quarter of FY2013. Moreover this Quarter is
always slightly more difficult to manage because of the slowdown
related to summer vacation. The limited growth in the manufacturing
sector in Asia has also affected our sales during this first
Quarter. However, we have managed to keep our Operating Expenses to
the same level as last year in spite of a growth of activities. Mr.
Forget continued:"We have recently concluded a 1 M$ private
investment from a German company, Zwick/Roell AG, and this has
reinforced our business partnership which already existed.
Now with two strong strategic partners, RAL Diagnostics and
Zwick/Roell AG, a healthier improved financial position, we are
able to pursue our developments projects in the biomedical sector
with enthusiasm." The board has granted a total of 470,000 stock
options to board members and employees of the Company on September
11(th), 2012. After this grant, a total of 1,634,981 stock options
remain available according to the total outstanding shares and the
stock option plan rules in force. About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research
microscopy laboratories. Clemex's customer base spans over many
countries in America, Europe, Asia and encompasses major Research
and Development Centers, prestigious Universities and large
manufacturing industries in various fields including healthcare,
automotive, aerospace, raw materials manufacturing,
pharmaceuticals, mining and other sectors. The CDNX has not
reviewed and does not accept responsibility for the adequacy and
accuracy of this press release. CLEMEX TECHNOLOGIES INC. CONTACT:
CLEMEX TECHNOLOGIES INC, 800 Guimond,Longueuil, QC, Canada J4G
1T5,Contact:Clement Forget,President and CEOTel: 450.651.6573Email:
ir@clemex.com
Copyright